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ABSTRACT
Objective: 
This institutional study was designed to determine the relative frequency of odontogenic tumors and to provide 
the information with reference to age, sex, anatomic location, and also to compare the data with the previous 
reports from other studies. 
Material and methods: 
A total of 489 cases of odontogenic tumors registered over a period of 38 years (February 1970 - March 2008) in 
the Department of Oral and Maxillofacial Pathology of Tamil Nadu Government Dental College and Hospital, 
Chennai, India were retrieved from the files of histopathology registers and were retrospectively analyzed.  
Results:
Odontogenic tumors in the present study constituted 4.13% of all the 11843 registered biopsies. The mandible 
was  the  most  commonly  affected  anatomic  location  with  362  cases  (74.02%).  Ameloblastoma  with  a 
predilection  for  posterior  mandible  was  the  most  frequent  odontogenic  tumor  (67.68%),  followed  by 
adenomatoid odontogenic tumor (9%), odontoma (7.77%) and calcifying odontogenic cyst (5.52%). The patients 
were affected over a wide age range of 5-75 years with a mean age of 32.64 years and peak occurrence in 2nd and 
3rd decades of life. Among the 489 cases only 15 cases (3.07%) were malignant. 
Conclusion: 
The incidence of 4.13% of odontogenic tumors observed in this study is the largest series from this part of the 
world. Ameloblastoma formed the single most common tumor of all odontogenic tumors. This study observed 
both regional and geographic variations in the frequency and distribution of odontogenic tumors. 
Key Words: 
Odontogenic  tumors;  Incidence;  Tamil  Nadu;  Government;  Chennai;  India;  Ameloblastoma;  Adenomatoid 
odontogenic tumor. 
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 INTRODUCTION 
Odontogenic tumors are the lesions derived from epithelial, ectomesenchymal, or both elements 
of odontogenic apparatus or its remnants. The spectrum of biological behaviour of these tumors ranges 
from non neoplastic to benign but locally destructive, to lesions with metastatic capabilities.1 These are 
unique and specific lesions to the jaws, but are relatively uncommon. A review of literature regarding 
the frequency of occurrence of odontogenic lesions in various populations revealed that they account 
for 1-32% of all the lesions occurring in the oral cavity 2, 3, 4. 
Odontogenic tumors constitute a heterogenous group of lesions with diverse histopathological 
features. They possess two major characteristics in that they arise from the tissue with the potential for 
differentiation into tooth or periodontal structures, and are therefore, found exclusively in the mandible 
and maxilla, and on rare occasions, gingiva. Another variable but distinct feature includes the display 
of  various  inductive interactions  of  primitive  epithelium and ectomesenchyme that  normally occur 
among the two embryonic components in the developing tooth germ and result in formation of tooth 
related  extracellular  substances,  some  of  which  may calcify  and  be  visible  on  radiographs15.  The 
specific histological structures reflect various stages of odontogenesis. 
             Odontogenic Tumors are usually slow growing and asymptomatic lesions. Certain Odontogenic 
tumors have a predilection for particular age groups, gender specificity, and anatomic locations. The 
most common sites of these tumors are the mandibular molar region and maxillary cuspid region.
A number of studies from different countries have been conducted and published. These 
studies have documented the demographic characteristics in their respective population with respect to 
age,  gender  and  site  of  involvement.  These  reports  also  indicate  the  differences  in  the  relative 
frequency of individual odontogenic tumors, suggesting geographic variations in different parts of the 
world. 
Although the global incidence of odontogenic tumors can be ascertained based on the 
documented  literature,  the  incidence  and  regional  variations  pertaining  to  the  occurrence  of 
odontogenic tumors among Indian population is difficult to ascertain. The problem stems from two 
factors: firstly, there is not much available published data from this part of the world except for a single 
report in recent years from the state of Maharashtra, India, which cannot be representative of the entire 
population of India. Since diverse group of people (defined by race and religion) are concentrated in 
different  parts  of  the  country  (represented  by  states  and  different  linguistic  and  cultural  habits) 
assessment of the relative incidence in different population groups would be of paramount importance 
to understand the regional variations in the incidence of odontogenic tumors, if any. And secondly, to 
overcome the paucity of available information efforts were made to collect information from individual 
dental teaching hospitals in India, (annexure I) but the information was very much limited for any 
meaningful comparison.
 In  view of  this  limited  published information,  as  mentioned above,  it  was  deemed 
prudent to gather a baseline data to determine the relative frequency and distribution of various types of 
odontogenic  tumors  from  the  biopsy  records  of  the  Department  of  Oral  Pathology,  Tamil  Nadu 
Government Dental College and Hospital. Since it is the only tertiary referral centre for dental health in 
the ministry of health and family welfare, Government of Tamil Nadu, information from the biopsy 
register over a period of 38 years would provide reliable data for future research as it caters to the 
dental needs of the population of Chennai which has an estimated population of 7.5 million in 2007 
spreading over an area of 174 sq.km5. Although there are approximately ten dental teaching hospitals in 
Chennai, this institution is the oldest of all with a high patient inflow from Chennai as well as from 
other parts of Tamil Nadu and the neighboring state of Andhra Pradesh. 
The purpose of this study, is therefore, to examine the epidemiology of odontogenic tumors and 
in particular, to provide the data with reference to age, sex, site and histologic subtypes of these lesions 
reported  in  this  part  of  the  country,  and  also  to  provide  the  data  for  comparison  with  other 
epidemiologic  findings  in  different  geographic  locations  in  order  to  detect  subtle  population 
differences. 
AIMS AND OBJECTIVES
This retrospective study aims –
1. To determine the relative frequency of odontogenic tumor types.
2. To provide the data with reference to age, sex, anatomic location and histologic subtypes of these 
lesions  reported in  the Department  of Oral  Pathology and Microbiology,  Tamil  Nadu Government 
Dental College and Hospital, Chennai, South India from 1970 to 2008. 
3. To compare the data both within and outside India, and to provide data for future epidemiological 
research. 
REVIEW OF LITERATURE
   Section I:   Frequency 
Gunhan et al in 19906  did a multicentric, collaborative retrospective study of 409 cases of 
odontogenic  tumors  in  Turkey.  In  their  study,  odontogenic  tumors  constituted  1.3%  of  all  oral 
specimens. There were 403 benign and 6 malignant odontogenic tumors in that series. Of the benign 
tumors, ameloblastomas were the most frequent lesions constituting 149cases (36.5%), followed by 74 
cases  (18%)  of  odontomas,  11  cases  of  AOT,  and  6  cases  of  CEOT.  Sixty  two  cases  of 
cementoblastoma, 51 cases of odontogenic myxoma, and 18 cases each of ameloblastic fibroma and 
odontogenic fibroma were also seen. Of the malignant neoplasms, 5 cases of malignant ameloblastoma 
and one of ameloblastic fibrosarcoma were found. 
Odukoya in 19952 analyzed 289 cases of odontogenic tumors in a Nigerian population over a 
period of 21 years (1971-1991) which constituted 19% of tumors and tumor-like lesions of the oral 
cavity and the jaws. Benign odontogenic tumors were seen more frequently (274 cases; 94.8%) than 
malignant odontogenic tumors (15 cases; 5.2%). He found ameloblastoma to be the most prevalent 
odontogenic tumor accounting for 58.5 % (169 cases). Also noted were 18 cases (6.23%) of AOT, 3 
cases of SOT (1.04%) and only 1 CEOT (0.35%). The 2nd category showed 13 cases of ameloblastic 
fibroma constituting 4.5%, 12 cases of odontoma (4.15%), and 7 cases of COC (2.42%). Among the 
tumors  of  ectomesenchymal  origin  myxoma  was  most  prevalent,  accounting  34  cases  (11.76%), 
odontogenic  fibroma 13 cases  (4.50%),  and  cementoblastoma 2 cases  (0.69%).   Of the  malignant 
tumors, odontogenic carcinoma was the most prevalent tumor affecting 14 patients (4.84%), whereas 
only 1 case of odontogenic sarcoma was found. 
Chidzonga et al in 1996 7 did a study entitled “Odontogenic Tumors: Analysis of 148 cases in 
Zimbabwe”. In their retrospective study of a total of 1723 biopsies over a 10 year period, 8.6% was the 
frequency of occurrence of odontogenic tumors. Of the total cases, ameloblastoma was the commonest 
odontogenic  tumor  accounting  for  79.1%.  The  only  malignant  odontogenic  tumor  noted  was 
ameloblastic fibro-sarcoma.
Arotiba et al in 1997 8 in a 15 year (1980-1994) retrospective review of oral and jaw tumors 
from Ibadan, Nigeria, found the prevalence of odontogenic tumors to be 30%, as only 128 cases out of 
423 were confirmed histologically to be odontogenic tumors. Ameloblastoma was the most common 
histological type (n=76, 59%), followed by odontogenic myxoma (n=21, 16%), AOT (n=16, 13%). 
COC, CEOT and central odontogenic fibroma constituted for 2% each, whereas there was no odontome 
and cementoblastoma in their study. Of the malignant lesions, only 2 cases of PIOC and 1 case of 
ameloblastic fibrosarcoma was found. 
Taylor  et  al  in  1997  9 conducted  a  collaborative  retrospective  study  of  349  cases  of 
odontogenic tumors in Mexico.  The frequency of odontogenic tumors was 2.5%. 345 were benign 
tumors constituting 98.8% and 4 were malignant (1.1%). The most frequently occurring tumors were 
odontoma (34.6%),  ameloblastoma (23.7%),  and myxoma (17.7%),  followed by AOT (7.1%),  and 
COC (6.8%). Other less common types of lesions found were ameloblastic fibroma (1.4%), central 
odontogenic fibroma (1.4%), cementoblastoma (0.8%), and CEOT (0.8%). In the malignant category, 3 
were primary intraosseous carcinomas and 1 was malignant ameloblastoma. 
Yong Lu et al in 199810 did a study entitled “Odontogenic tumors: A demographic study of 759 
cases in a Chinese population” over a period of 43 years (1952-1994). Among these cases, 93.9% of the 
tumors  were benign (n=713) and 6.1% were malignant  (n=46).  Ameloblastoma predominated with 
58.6%, followed by odontogenic myxoma (8.4%), and AOT (8.3%), while odontomas accounted for 
only 6.7%. Malignant  ameloblastoma (3.2%) was the most  frequent  malignant  odontogenic tumor, 
followed by PIOC (1.4%). 
Santos et al in 200111 did analysis of 127 cases of odontogenic tumors reported over a period of 
30 years (1970-1999). All cases were benign lesions whereas they found no malignant tumor. Sixty 
four tumors were diagnosed as odontomas, which corresponded to the most frequent tumor, accounting 
for 50.4% of all cases followed by 39 cases of ameloblastoma accounting for 30.7%. Eleven cases of 
AOT (8.67%), 6 cases of odontogenic myxoma (4.72%), and 3 cases of cementoblastoma (2.37%) were 
also found.
Ochsenius et al in 200212 conducted a study of 362 cases of odontogenic tumors registered over 
a period of 25 years (1975-2000) in Chile. The frequency of odontogenic tumors as a percentage of all 
pathological specimens was 1.29%. Of the 362 odontogenic tumors, 360 were benign (99.4%) and only 
2 were malignant (0.6%). The most frequent histological type was odontomas, constituting 162 cases 
(44.7%),  followed by 74 cases  of  ameloblastoma (20.4%),  and  32 cases  of  myxoma (8.8%).  Rest 
comprised 26 cases (7.2%) of COC, 24 cases of AOT (6.6%), and 20 cases of odontogenic fibroma 
(5.5%).  SOT, CEOT, CCOT, ameloblastic  fibroma and ameloblastic  fibrodentinoma accounted for 
0.6% each (2 cases  each).  Of the malignant,  one case of  odontogenic carcinosarcoma and one of 
ameloblastic fibroodontosarcoma was found. 
Simon et al in 200213 published a retrospective study of  Odontogenic tumors and tumor-like 
lesions in Tanzania recorded during a period of 15 years (1982-1997). In their  study,  odontogenic 
tumors comprised about 12.2% of all oral tumors and tumor-like conditions. Ameloblastoma was the 
most commonly seen odontogenic tumor (73.7%), followed by odontogenic myxoma (10.3%).
Adebiyi et al in 200414  conducted analysis of 197 ectodermal odontogenic tumors observed 
during a period of 21 years (1973-1993) in a Nigerian population. Of the 197 cases, 182 (92.3%) were 
benign while 15 (7.6%) were malignant. Central ameloblastoma, which accounted for 88.3% (n=174) 
in the series, was the most common benign neoplasm. Ameloblastic carcinoma was the most prevalent 
malignant tumor (n=11, 5.6%). 
Tamme  et  al  in  200415 conducted  a  collaborative  retrospective  study  of  75  cases  of 
odontogenic tumors, covering more than 25 years from Estonia. The frequency of odontogenic tumors 
in  their  study  was  the  lowest  ever  reported;  as  out  of  total  10,141  biopsies,  only  75  cases  of 
odontogenic tumors were identified, accounting for 0.74% only.  Of the 75 cases, 74 (98.6%) were 
benign and 1(1.3%) was malignant. The most frequent benign tumor was odontoma (34.3%), followed 
by ameloblastomas (25.3%),  ameloblastic  fibroma (16%),  odontogenic myxoma (12%) and benign 
cementoblastoma (8%). The other less common types were CEOT and AOT, accounting for 1.3% each. 
The only malignant tumor was PIOC. 
Adebayo et al in 20054 reviewed 318 odontogenic tumors registered during a period of 20 
years (1979-1998) in Kaduna, Nigeria. The frequency of odontogenic tumors as a percentage of all 
tumor and tumor like lesions of the oral and paraoral  structures (990 cases) was 32%. Of the 318 
tumors, 314 (99%) were benign lesions and 4 (1%) were malignant. Ameloblastoma made up 73% (233 
cases) of the tumors, followed by odontogenic myxoma 38 (12%), ameloblastic fibroma 9 (3%), and 
the AOT (2%). Among the malignant types, there were 3 odontogenic carcinomas and 1 odontogenic 
sarcoma. 
Simon et al in 200516 conducted a 4-year (1999-2003) prospective study on epidemiology and 
clinicopathological presentation of odontogenic tumors in Tanzanian population. A total of 116 patients 
were seen during this period. The authors have concluded that frequency of ameloblastoma (80.1%) far 
outnumbered the frequency of other odontogenic tumors. 
Ladeinde et al in 20053 did a study entitled “Odontogenic tumors: A of 319 cases in a Nigerian 
teaching hospital”. They found that odontogenic tumors constituted 9.6% (319cases) of all the 3337 
biopsies of oral and jaw lesions seen within a period of 24 years (1980-2003). 308 tumors (96.6%) 
were located intraosseously, and 11 (3.4%) were peripheral. Among the peripheral lesions there were 7 
cases  of  peripheral  odontogenic  fibroma,  3  cases  of  peripheral  myxoma  and  1  of  peripheral 
ameloblastoma. The same ratio was observed between benign and malignant lesions i.e. 308 (96.6%) 
were benign and 11 (3.4%) were malignant lesions. Ameloblastoma was the most frequent odontogenic 
tumor  (63%),  followed  by AOT (7.5%),  myxoma (6.5%),  COC (5.3%),  and  odontogenic  fibroma 
(5.3%). More cases of malignant odontogenic tumors were seen than cases of CEOT and odontomas. 
Ameloblastic carcinoma was the most common of malignant odontogenic tumors. 
Fernandes et al in 200517 did a study of 340 cases of odontogenic tumors reported over a 
period  of  51  years  (1954-2004)  in  a  Brazilian  population.  The  frequency  of  odontogenic  tumors 
comprised of 1.78% of all pathologic specimens during a period of 50 years. There were 338 (99.4%) 
benign  lesions  and  only  2  (0.6%)  malignant  lesions.  The  most  frequent  benign  tumor  was 
Ameloblastoma 154 cases (45.2%), followed by odontomas 85 cases (24.91%), and myxoma 31 cases 
(9.1%).  13 cases  of  AOT and 12 cases  of  COC follow next.  The  malignant  lesions  included one 
ameloblastic carcinoma and a clear cell odontogenic carcinoma (CCOT). 
Buchner et al in 200618 did a study titled “Relative Frequency of Central Odontogenic Tumors: 
A Study of 1,088 Cases from Northern California and Comparison to Studies from Other Parts of the 
World”. Odontogenic tumors comprised 1088 cases out of 91,178 biopsies accessed during the 20 year 
period,  thus  accounting  for  a  general  frequency of  1.2%.  Individually,  of  all  tumors,  75.9% were 
odontomas. The prevalence of the remaining tumors appears to be a rare occurrence. The second most 
common was ameloblastoma (11.7%), followed by odontogenic myxoma (2.2%). 
Jing et al in 200619 did a study titled “Odontogenic Tumors: a retrospective study of 1642 cases 
in a Chinese population”. These cases were registered over a 52-year period (1952-2004). Of these 
tumors 1592 (97%) were benign and 50 (3%) were malignant. Ameloblastoma (661 cases, 40.3%) was 
the most frequent type, followed by keratocystic odontogenic tumor (588 cases, 35.8%), odontoma (78 
cases, 4.7%), and odontogenic myxoma (76 cases, 4.6%). Sixty eight cases of AOT, 45 cases of COC, 
33  cementoblastoma,  19  ameloblastic  fibroma  and  10  cases  of  CEOT  were  found.  Among  the 
malignant lesions, ameloblastic carcinoma was most prevalent with 27 cases, followed by 14 cases of 
PIOC. 
Olgac et al in 200620 studied 527 cases of Odontogenic Tumors in Istanbul. Out of total 62,565 
cases registered in their department from 1971 to 2003 (32 years period), 527 cases of odontogenic 
tumors constituted even less than 1% (0.83%). There were 521 benign tumors and 6 malignant. The 
common  lesions  were  Ameloblastoma  (n=133,  25%),  followed  by  odontoma  (n=109,  21%),  and 
odontogenic myxoma (n=83, 16%). 
Okada et al in 200721 conducted a study titled “Odontogenic Tumors in Sri Lanka: Analysis of 
226 Cases”. They analyzed 226 cases reported from 1996 to 2002 (7 years duration). Of these 226 
cases, 220 (97.3%) were benign and only 6 (2.7%) were malignant. The most frequent benign tumor 
was ameloblastoma (157 cases; 69.8%), followed by adenomatoid odontogenic tumor (21 cases; 9.3%), 
odontogenic myxoma (11 cases; 4.9%), and odontomas and calcifying odontogenic cysts  (10 cases 
each; 4.4%). Clear cell odontogenic carcinoma (3 cases; 1.3%) was the most frequent malignant tumor; 
the  other  malignancies  included  primary intraosseous  carcinoma (2  cases;  0.9%) and ameloblastic 
fibrosarcoma (1 case; 0.4%). 
Sriram et al in 200822 conducted a retrospective study of 250 cases of Odontogenic Tumors 
managed during a period of 36 years (1971-2006) in an Indian teaching hospital. Of the 250 tumors, 
247 were benign and only 3 were malignant. Of the latter, all 3 were ameloblastic carcinomas. In the 
benign lesions, ameloblastoma predominated with 154 cases (61.6%), followed by 31 cases of AOT 
(12.4%), 15 cases (6%) each of odontoma and myxoma. The rest comprised 12 cases of odontogenic 
fibroma, 7 cases of COC (2.8%), and 6 cases of CEOT (2.4%). 
Section II: Age 
Gunhan et al in 19906  did a multicentric, collaborative retrospective study of 409 cases of 
odontogenic tumors in Turkey. The average age of the patients was 31 years for benign tumors and 
24.6 years for the malignant ones, with an age range of 2 to 86 years. Ameloblastoma affected patients 
in the age range of 5-86 years with a mean age of 36.7 years. For AOT patients, age ranged from 15 – 
50 years with a mean age of 20.2 years. Ameloblastic fibroma affected the youngest,  a 2 year old 
patient, and ranged upto 42 years with a mean age of 31 years. Odontoma showed a wide age range of 
9 to 60 years with a mean of 26.3 years.  
Odukoya et al in 19952 conducted a retrospective study of 289 cases of odontogenic tumors in 
a Nigerian population. They analyzed that the age range varied from 2.5 to 82 years. The youngest, a 2 
½ year old patient, was a case of ameloblastic fibroma and the oldest, an 82 years old patient, in the 
series was a case of ameloblastoma. They found that the first group of benign tumors ranged in age 
from 10-82 years with a mean of 29 years. The second group showed an age range of 2.5-54 years with 
a  mean of  18 years.  The 3rd group ranged from 5-78 years of  age with a mean of 20 years.  The 
malignant tumors showed a mean age of 35 years. Analysis of 169 cases of ameloblastoma in their 
series showed that it occurred in the widest age range from 0-82 years with a mean age of 31 years. 
Arotiba et al in 19978 in a 15 year retrospective review of oral and jaw tumors from Ibadan, 
Nigeria, observed that the odontogenic tumors were most common in the 2nd to 4th decade with a peak 
incidence in 3rd decade (n=36). In general, the patient’s age ranged from 8-75 years, about 70% of the 
patients being between 11 and 40 years. For ameloblastoma, the patients age ranged from 8 to 72 years 
with a mean of 33 years and a median age of 30 years. AOT affected patients over a significantly wide 
age range of 9 to 75 years with a mean age of 22 years. 
Yong Lu et al in 199810 did a study titled “Odontogenic tumors: A demographic study of 759 
cases in a Chinese population”. The mean age of this patient population was 29.3 years with a wide 
range of 3-77 years. 525 cases (69.2%) were found during the 2nd, 3rd, and 4th decade, with a peak in the 
3rd decade (27.5%). Ameloblastic fibroma (mean age, 23.9 years), ameloblastic fibro-odontoma (mean 
age, 23.5 years), odontoameloblastoma (mean age, 15 years), adenomatoid odontogenic tumor (mean 
age,  22.6 years), compound odontoma (mean age,  17 years), odontogenic fibroma (mean age, 16.4 
years), odontogenic myxoma (mean age, 19.6 years), and benign cementoblastoma (mean age, 20.7 
years)  were  the  odontogenic  tumors  most  commonly  seen  in  younger  patients.  The  malignant 
odontogenic tumors had a predilection for patients more than 40 years of age. 
Santos et al in 200111 analyzed 127 cases which showed age range from 4 to 82 years with 
peak incidence in 2nd and 3rd decades of life and average of 26.6 years.  
Ochsenius et al in 200212 reviewed 362 cases of odontogenic tumors in Chile. The age range 
for odontogenic tumors as a whole was from 1 to 82 years. The average patient age was 25.2 years for 
benign tumors. With regard to benign tumors, there was no significant difference in age distribution 
with a mean of 24.5 years for males and 25.8 years for females. Odontomas peaked in 2nd decade. 
Myxomas and COC also present a greater frequency in 2nd decade, but not as pronounced as in the case 
of  the odontomas.  Ameloblastomas showed a bimodal  curve  with  one  peak  in  the 3rd decade and 
another in 5th decade. Regarding AOT, 88% cases were distributed between age 12 and 25. 
Simon et al in 200213 did a study of Odontogenic tumours and tumour-like lesions in Tanzania. 
In their study, the majority of odontogenic tumours (55.3%) were seen in patients below 30 years of 
age. 
Adebiyi et al in 200414 conducted analysis of 197 ectodermal odontogenic tumors in a Nigerian 
population. The tumors occurred over an age range of 8-85 years, with a peak age incidence in the 3rd 
decade.  Benign lesions were most common in the 3rd decade while the malignant ones presented more 
frequently in the 2nd and 4th decades. Central  ameloblastoma, which was the most common benign 
neoplasm in this study showed an age range of 9-82 years with a mean age of occurrence (±SD) 31.0 ± 
13.9.  Similarly  the  mean  age  (±SD)  was  30.1±20.7.  Age range  was  16-85 years  for  ameloblastic 
carcinoma, which was the most prevalent malignant tumor in this study. For SOT the mean age of 
occurrence was 36.6±10.0 (range 20-45) years. 
Tamme et  al  in  200415 conducted  a  collaborative  retrospective  study  of  75  cases  of 
odontogenic tumors, covering more than 25 years from Estonia. Of the 75 cases, 51 cases (68%) were 
found during the 2nd, 3rd, and 4th and 6th decade of life. 
Adebayo et al in 20054 conducted a review of 318 odontogenic tumors in Kaduna, Nigeria. The 
patients ranged in age from 1 to 78 years with the mean age of 29 years. Ameloblastoma, myxoma and 
ameloblastic fibroma peaked in 3rd decade, whereas AOT and odontoma peaked in 2nd decade. Cases of 
CEOT were seen only in 6th decade between 50-55 years of age. Ameloblastoma showed the widest age 
range from 7 to 75 years with mean age of 29 years. 
Simon et  al  in  200516 conducted  a  4-year  prospective  study  on  epidemiology  and 
clinicopathological  presentation  of  odontogenic  tumors  in  Tanzania.  Most  (71%)  patients  with 
odontogenic tumors were in the age group of 10 to 39 years with a mean of 32 years.  Ameloblastoma 
occurred with a mean age of 35 years. The 9 cases of unicystic ameloblastoma occurred over a wide 
age range of 15 to 50 years with a mean of 27 years.
Ladeinde et al in 20053 did a study titled “Odontogenic tumors: A review of 319 cases in a 
Nigerian teaching hospital”. The mean age of patients was 29.9±15.6 years in a wide age range of 4-85 
years.  No  significant  difference  was  found  between  the  mean  ages  of  the  patients  with  benign 
odontogenic tumors and those with malignant odontogenic tumors (P=.058). Odontogenic tumors were 
most frequent in the 2nd to 5th decade, 88.1% of patients being between 11 and 50 years. The mean age 
(±SD) of patients with ameloblastoma was 31.7±15.3 years (range, 4-82 years) with a peak incidence in 
the 3rd decade. The mean age (±SD) of patients with AOT (16.6±5.7), ameloblastic fibroma (15.7±3.0), 
and odontoma (22.3±11.2) were significantly lower than those with ameloblastoma (P<.05).
Fernandes et al in 200517 did a study of 340 cases a Brazilian population. The mean age of 
their patient population was 25.5, with a wide range (1-82 years). About 250 cases were found in 2nd, 
3rd and 4th decades, with a peak in the 2nd decade i.e.112 cases (32.9%), followed by 87 cases in 3rd 
decade, 51 in 4th decade, 29 in 5th decade, and 11 in 6th decade. The most prevalent odontogenic tumor 
in  the 2nd decade of life  was ameloblastoma (42%), followed by odontoma (28.3%), and myxoma 
(9.8%). Except in the 1st decade where the most prevalent lesion was odontoma, ameloblastoma was the 
most predominant in rest of the decades.  
Buchner et al in 200618 did a study titled “Relative Frequency of Central Odontogenic Tumors: 
A Study of 1,088 Cases from Northern California and Comparison to Studies from Other Parts of the 
World”. For odontomas, age at the time of treatment was known for 762 patients out of 826 cases. The 
age ranged from 1 year to 90 years with a mean of 18.4 years and median 15 years. The highest 
frequency was in the 2nd decade (56.2%). Of these 127 cases of ameloblastoma, solid ameloblastoma 
accounted for 69 cases and 58 cases formed the unicystic  type.  In those solid ameloblastoma,  the 
patient’s age ranged from 14 to79 years (mean 48 years, median 48 years) with the maximum cases 
reported in 5th decade of life. And for unicystic ameloblastoma, the corresponding figure ranged from 
10 to 71 years (mean 29.4 years, median 24 years) with the maximum number of cases found in the 2nd 
decade.  For CEOT, patients ranged in age from 44 to 58 years (mean 51.6years, median 54 years).
 For AOT, patients ranged in age from 4 to 47 years (mean 20.2 years, median 15 years). The 
highest frequency was in the 2nd decade, with 50% of the patients in this age group. 17 patients of 
ameloblastic fibroma ranged in age from 3 to 26 years (mean 9.2 years, median 8 years). The highest 
frequency was in the 1st decade, with 65% of the patients in this age group. There were 25 cases of 
odontogenic myxoma. The patients ranged in age from 13 to 69 years (mean 36.1 years, median 37 
years). The highest frequency was in the 4th and 5th decade, with 57% of the patients in these age 
groups.  Benign cementoblastoma patients ranged in age from 9 to 33 years (mean 19.8 years, median 
20 years). 
Jing et al in 200619 conducted a study titled “Odontogenic Tumors: a retrospective study of 
1642 cases in a Chinese population”. The age of the patients ranged from 3 to 84 years with a mean age 
of 32.1 years.  67.6% of cases were distributed between age 10 and 39 with a peak incidence in the 3rd 
decade (27.6%), except AOT and odontoma which showed a significant predilection for 2nd decade. 
Malignant tumors occurred more frequently in the 5th and 6th decade of life. 
Olgac et al in 200620 studied 527 cases of Odontogenic Tumors in Istanbul. The ages of the 
affected  patients  varied  widely  (range  3-85  years).  The  tumors  occurred  mainly  in  young  people 
between the ages of 10 to 39 (n=352, 67%). The maximum number of lesions affected patients in 2nd 
and 3rd decade (n=236) except COC which showed predominance after 60 years of age. 
Okada et al in 200721 conducted a study titled “Odontogenic Tumors in Sri Lanka: Analysis of 
226 Cases”. For all odontogenic tumors, the age of occurrence ranged from 1 to 84 years (average, 31.4 
years). Most cases (175; 77.4%) occurred in the second to fifth decades of life, with a peak in the 
second decade (54 cases; 23.9%). The average age of occurrence was 33.2 years for ameloblastoma, 
18.2 years for adenomatoid odontogenic tumor, 33.9 years for myxoma, 23.9years for odontoma, and 
34.9 years for calcifying odontogenic cyst. Peak incidence occurred in the second decade for all of 
these tumors except ameloblastoma, which had the highest prevalence in the fourth decade. 
Sriram et al in 200822 retrospectively analyzed 250 cases of odontogenic tumors registered 
over  a period of 36 years in an Indian teaching hospital  in Mumbai,  India.  The mean age of this 
population  was 29.81  years,  with  a  wide  range  of  2.5  to  75  years.  Age distribution  of  all  of  the 
odontogenic tumors showed a peak occurrence in the 3rd decade, with 83.6% of the cases occurring 
between the 2nd and 5th decade. Ameloblastoma, the most common tumor in this study, showed a peak 
occurrence in the 3rd decade, with 74% of the cases in 3rd decade. AOT and myxoma predominantly 
occurred in 2nd decade.  A comparison of mean age of presentation of the common odontogenic tumors 
in  their  study  showed  that  AOT  and  myxoma  occurred  at  significantly  lower-aged  individuals 
compared with ameloblastomas. 
Section III: Gender 
Gunhan et al in 19906  did a multicentric, collaborative retrospective study of 409 cases of 
odontogenic tumors in Turkey. Of the 409 cases, 203 were males and 196 were female patients. In 
contrast  to general  male predominance AOT, cementoblastoma,  and odontogenic myxoma affected 
female patients more than male patients. 
 Odukoya et  al  in  19952 in  a  retrospective  study of  289 cases  of  odontogenic  tumors  in  a 
Nigerian population,  found a general  prediction for males constituting 56.1% whereas 43.9% were 
female  patients.  Benign  odontogenic  tumors  categorized  as  of  “odontogenic  epithelium  without 
odontogenic ectomesenchyme” were more common in males (65.3%) than females (37.7%), whereas 
those categorized as of “odontogenic epithelium with odontogenic ectomesenchyme, with or without 
dental  hard tissue formation” occurred more frequently in females (63.5%) than in males (36.5%). 
Adenomatoid odontogenic tumor, which occurred more than twice as commonly in females (72.2%) as 
in  males  (27.8%)  was  the  most  frequently  observed  odontogenic  tumor  in  this  category.  Further 
observation showed that malignant odontogenic tumors were slightly more common in males (53.3%) 
than females (46.7%). 
Arotiba et al in 19978 in a 15 year retrospective review of oral and jaw tumors from Ibadan, 
Nigeria, reported almost equal sex prevalence with an overall male: female ratio of 1.1:1. Of the 76 
cases  of  ameloblastoma,  45  were  male  and  31female  patients,  the  male:  female  ratio  being  3:2. 
Adenomatoid  odontogenic  tumor  affected  male  and  female  patients  with  an  equal  frequency. 
Fibromyxoma showed a female predominance with 13 female and 8 male patients (M: F ratio 2:3). 
Taylor et al in 19979 conducted a collaborative retrospective study of 349 cases of odontogenic 
tumors  in  Mexico.  In  their  study they reported  an  overall  female  predominance  with  193 female 
patients (55.3%) and 154 male patients (44.1%). Ameloblastoma, AOT, myxoma, and odontoma all 
showed a female predominance, though the only malignant tumor, the odontogenic carcinoma occurred 
only in males.
Yong Lu et al in 199810 did a study titled “Odontogenic tumors: A demographic study of 759 
cases in a Chinese population”. In their study they found that 428 cases were male and 329 were female 
patients, gender description was not specified for 2 cases. Notably, malignant tumors were significantly 
more common in male than in female patients (M: F ratio, 2.1:1), whereas benign tumors showed 
almost equal gender prediection (M: F ratio 1.1:1). 
Santos et al in 200111 reported in their analysis of 127 cases that more than 60% of all tumors 
occurred in females and 36.22%, in males.  Out of the 39 cases  of ameloblastoma,  22 occurred in 
females and 17 in male patients. Like wise AOT, benign cementoblastoma, ameloblastic fibroma and 
odontomas also showed female predominance. 
Ochsenius et al in 200212 in their study on 362 cases of odontogenic tumors reported an overall 
female predominance with 194 females (53.59%) and 168 male patients (46.40%). Ameloblastoma, 
odontoma and myxoma showed a female predominance whereas AOT and benign cementoblastoma 
affected more of male patients.
Adebiyi et al in 200414 conducted analysis of 197 ectodermal odontogenic tumors in a Nigerian 
population. The tumors were found to be more common in males (114 cases, 57.9%) than females (83 
cases, 42.1%). Exception was SOT, which occurred exclusively in females (63.6%). Ameloblastoma 
showed a male to female ratio of 1.5:1. 
Tamme et  al  in  200415 conducted  a  collaborative  retrospective  study  of  75  cases  of 
odontogenic tumors, covering more than 25 years from Estonia. The 75 lesions were distributed in 28 
males and in 47 females, thus showing a clear female predominance, and the overall male to female 
ratio of 1:1.7. 
Simon et  al  in  200516 conducted  a  4-year  prospective  study  on  epidemiology  and 
clinicopathological presentation of 116 cases of odontogenic tumors in  Tanzania. In their study, they 
reported  an  overall  female  predominance  with  58  female  and  53  male  patients.  Gender  was  not 
specified for 5 cases. Ameloblastoma had an equal distribution between males and females.
Adebayo et al in 20054 conducted a review of 318 odontogenic tumors in Kaduna, Nigeria. 
There was a general male predominance with 183 cases (57.55%) and 135 female patients (42.45%). 
The male:  female ratio  being 1.35:1.  Individually all  lesions  showed a male predominance except 
odontogenic myxoma, which notably showed female predominance with M: F ratio being 1:2.8.
Ladeinde et al in 20053 did a study titled “Odontogenic tumors: A review of 319 cases in a 
Nigerian teaching hospital”. In their study, there was an overall male: female ratio of 1:1 with 162 male 
and 157 female patients. Malignant odontogenic tumors occurred more in males than females (7:4). 
Among the benign lesions, ameloblastoma, CEOT, COC, odontogenic fibroma, and cementoblastoma 
were  more  prevalent  in  males  whereas  ameloblastic  fibroma,  AOT and myxoma were  seen  more 
commonly in female patients. 
Fernandes  et  al  in  200517 did  a  study  of  340  cases  a  Brazilian  population.  Of  the  340 
odontogenic tumors, the gender distribution was 187 females (55%), 152 males (45%) and one not 
related. This states a general female predominance except odontomas, which affected males more often 
than females. Benign tumors presented a male: female ratio of 1:1.2 and all malignant tumors were 
found in females. 
Buchner et al in 200618 did a study titled “Relative Frequency of Central Odontogenic Tumors: 
A Study of 1,088 Cases from Northern California and Comparison to Studies from Other Parts of the 
World”. For odontomas, information regarding gender was known for 762 patients out of 826 cases 
with almost equal distribution between males (51.2%) and females (48.8%). 
Males  were  more  frequently  affected  by  solid  type  ameloblastoma  than  females  (59%  and  41% 
respectively), whereas unicystic ameloblastoma affected females more frequently than males (59% and 
41% respectively). In cases of AOT there was almost equal distribution between genders involving 10 
females (52.6%) and 9 males (47.4%). Ameloblastic fibroma affected 11 males (65%) and 6 females 
(35%). Odontogenic myxoma showed a significant female predilection (74%). Males were affected 
more than females by benign cementoblastoma involving 7 males and 3 females. 
Jing et al in 200619 did a study titled “Odontogenic Tumors: a retrospective study of 1642 cases 
in a Chinese population”. The gender distribution was 959 male and 680 female patients with 3 cases of 
unspecified gender. The male-female ratio was 1.4:1 for benign lesions and 1.9:1 for malignant tumors. 
Their study showed a general male predominance except for AOT, odontoma, odontogenic myxoma, 
and cementoblastoma which affected female patients more than males. 
Olgac et al in 200620 studied 527 cases of Odontogenic Tumors in Istanbul. Overall there were 
more female patients (n=278, 53%) in their study than male patients (n=249, 47%). Ameloblastoma, 
AOT, benign cementoblastoma, odontogenic myxoma affected female patients more often than males. 
In contrast, odontomas affected male patients more than females. 
Okada et al in 200721 conducted a study titled “Odontogenic Tumors in Sri Lanka: Analysis of 
226 Cases”. The patient group showed a general female predominance which comprised 107 males 
(47.3%) and 119 females (52.7%). Of the 220 cases of benign odontogenic tumors, 103 (46.8%) were 
diagnosed in males and 117 (53.2%) in females. Of the 6 cases of malignant odontogenic tumors, 4 
(66.7%) were diagnosed in males and 2 (33.3%) in females. There was no gender predilection for 
ameloblastoma (1:1). The male-to-female ratio in calcifying epithelial odontogenic tumor (CEOT) was 
2:1. An apparent female predilection was seen for adenomatoid odontogenic tumor (1:2.5), compound 
odontoma (1:3), and myxoma (1:1.8). 
Sriram et al in 200822 retrospectively analyzed 250 cases of odontogenic tumors registered 
over a period of 36 years in an Indian teaching hospital in Maharashtra, India. Among the 247 benign 
tumors,  136 were found in males and 114 in  females  with an overall  male:  female ratio of 1.2:1. 
Gender analysis  of individual  benign tumor revealed a female predilection for most of the tumors 
except ameloblastoma, COC, and odontogenic fibroma. All the three cases of ameloblastic carcinoma 
preferably affected males, sparing the other sex. 
Section IV: Anatomical location
Gunhan et al in 19906  did a multicentric, collaborative retrospective study of 409 cases of 
odontogenic  tumors  in  Turkey.  Tumors  predominated  in  the  lateral  and  posterior  regions  of  the 
mandible  and  maxilla  (76%).  Of  the  149  cases  of  ameloblastoma,  71% involved  the  mandibular 
posterior area which was the predominant site for all odontogenic tumors. Complex and compound 
odontomas  predominate  in  different  regions,  the  former  involving  molar  and  the  altter  involving 
anterior regions more frequently. Only 24% of all tumors were located anteriorly, more frequently in 
female patients (27%) than in males (20%). 
Odukoya et al in 19952 in their study titled “Odontogenic Tumors: analysis of 289 Nigerian 
cases”  found  that  odontogenic  tumors  had  a  predilection  for  the  mandible,  although  adenomatoid 
odontogenic tumor, calcifying odontogenic cyst and odontogenic fibroma showed a predilection for the 
maxilla. Ameloblastoma had a site predilection for the posterior mandible (74%) with occurrence in the 
anterior mandible being 26%, and only 3 cases in the maxilla. Squamous odontogenic tumor, calcifying 
epithelial odontogenic tumor, cementoblastoma and malignant tumors showed 100% predilection for 
mandible with no case in the maxilla.
Arotiba et  al  in  19978 in  a 15 year  retrospective review of  128 odontogenic tumors  from 
Ibadan, Nigeria, reported an equal distribution between the mandible and the maxilla. 69 (91%) of the 
ameloblastoma patients had mandibular lesions and 7 (9%) had maxillary lesions. The most common 
site involved was the posterior mandible (horizontal ramus, n=44, 80%). The adenomatoid odontogenic 
tumor affected the maxilla in 11 patients (69%) with 8 tumors in the anterior maxilla, and the mandible 
in  5  patients  (31%).  The fibromyxoma affected  the  mandible  (n=10)  and the  maxilla  (n=11)  with 
almost equal frequency.
Taylor et al in 19979 conducted a collaborative retrospective study of 349 cases of odontogenic 
tumors in Mexico. There were 169 lesions in the mandible (50.7%) and 164 in the maxilla (49.2%). 
The most frequently affected areas were the posterior aspect of the mandible and the anterior region of 
the maxilla, with 59.1% and 53% of all tumors found in each location, respectively. 
Yong Lu et al in 1998 10 did a study titled “Odontogenic tumors: A demographic study of 759 
cases in a Chinese population”. They found a general predilection for mandible (mandible: maxilla 
ratio, 3.2:1) and this was particularly notable for ameloblastoma. In fact,  70.2% of the mandibular 
tumors were ameloblastomas as opposed to only 17.6% of the maxillary lesions. In contrast, COC and 
benign cementoblastoma occurred more commonly in maxilla and their respective maxilla-mandible 
ratios being 2.5:1 and 1.6:1. The odontogenic tumors in general most commonly occurred in the molar 
(27.9%) and angle regions (17.8%) of the mandible. AOT and COC were exclusively found in the 
anterior and the premolar regions of both jaws (adenomatoid odontogenic tumors, 88.9%; calcifying 
odontogenic cysts, 91.4%). 
Santos et al in 200111 reported in their analysis of 127 cases that in general, the mandible was 
the most frequent affected site, corresponding to 54.33% of the cases, while the maxilla was affected in 
40.15% cases. In their study, all the cases of ameloblastoma were exclusively located in the mandible. 
AOT and odontomas most frequently affected anterior maxilla whereas both the jaws were equally 
affected by myxoma. 
Ochsenius et al in 2002 12 studied 362 cases in Chile population. The mandible was a slightly 
more common site for occurrence for the total of benign odontogenic tumors, with a ratio of 1.14:1. It 
is worthwhile mentioning that the cases of CEOT and SOT were found exclusively in the maxilla. In 
general, odontomas were found in a greater number in the maxilla, especially in the anterior zone. The 
ameloblastic  fibroma  and  ameloblastic  fibrodentinoma  were  found  only  in  the  mandible.  81% 
ameloblastoma were observed in the mandible, most frequently in the molar zone. 
Adebiyi et al in 200414 conducted analysis of 197 ectodermal odontogenic tumors in a Nigerian 
population. Of the lesions in which the site could be identified (163 cases), the majority occurred in the 
mandible (82.7%) with only 10 (5.1%) cases presenting in the maxilla. The site of the tumors was not 
indicated in 21 cases.  Ameloblastoma occurred more frequently in  the mandible  (83.3%) than the 
maxilla  (4.0%).  The  most  common  site  of  the  mandible  involved  was  the  premolar-molar  region 
(75cases,  70.1%).  Four  out  of  the  five  cases  of  SOT  occurred  in  the  mandible  with  only  one 
presentation in the maxilla. 
Tamme et  al  in  200415 conducted  a  collaborative  retrospective  study  of  75  cases  of 
odontogenic tumors, covering more than 25 years from Estonia. In general, there was a predilection for 
mandible  (with  a  mandible  to  maxilla  ratio  of  1.6:1),  which  was  particularly  marked  for 
ameloblastomas (mandible to maxilla 2.8:1). In contrast, 2 out of 6 cementoblastoma occurs in the 
maxilla; the maxilla to mandible ratio being 1:2.  The most frequently affected areas were the premolar 
(20%) and molar regions (21.3%) in the mandible and the most common location in the maxilla was the 
premolar region (17.3%).  
Adebayo et al in 20054 conducted a review of 318 odontogenic tumors in Kaduna, Nigeria. 
Posterior mandible was found to be the mostly affected site. For ameloblastoma, the symphysis- body 
ramus region of the mandible (n=144; 62%) was the most favored site for tumor occurrence, followed 
by anterior region of the mandible (n=66, 28%). In cases of CEOT, the posterior part of either jaw was 
the most common site. Odontogenic myxoma occurred more in the mandible (n=20, 53%) than maxilla 
(n=18, 47%). 
Ladeinde et al in 20053 did a study titled “Odontogenic tumors: A review of 319 cases in a 
Nigerian teaching hospital”. Mandible to maxilla ratio was 4.1:1. of the 319 cases, 308 tumors (96.6%) 
were located intraosseous, and 11 (3.4%) were peripheral. Among the peripheral lesions were 7 cases 
of peripheral odontogenic fibroma, 3 cases of peripheral myxoma and 1 of peripheral ameloblastoma. 
Malignant odontogenic tumors occurred more in the mandible than the maxilla (8:3). Generally all 
lesions were more prevalent in mandible except AOT and COC, which occurred more in maxilla. 
Fernandes et al in 200517 did a study of 340 cases a Brazilian population. In their study exact 
location of the tumor was known in 319 cases. There were 110 (34.5%) cases in the maxilla and 209 
(65.5%) cases in the mandible. The most frequently affected areas were the posterior aspect of the 
mandible and anterior region of the maxilla, with 56.9% and 60% of all the tumors found in each 
location, respectively. The ameloblastic fibroma was found only in the mandible. About 85% of the 
ameloblastoma were  observed  in  the  mandible,  most  frequently  in  molar  zone.  The  complex  and 
compound odontomas were found principally in the anterior zone of maxilla, with 61.5% and 63.6% 
cases of each respectively. 
Buchner et al in 200618 did a study titled “Relative Frequency of Central Odontogenic Tumors: 
A Study of 1,088 Cases from Northern California and Comparison to Studies from Other Parts of the 
World”. Both solid and unicystic types of ameloblastoma involved mandible more than maxilla. 
The odontoma showed an almost  equal  distribution between maxilla (50.6%) and mandible 
(49.3%). Odontomas were most commonly encountered in anterior maxilla (37%), followed by anterior 
mandible  (25%),  posterior  mandible  (25%),  and  the  posterior  maxilla  (13%).  COC  showed  no 
significant predilection for the location of the lesion either in the maxilla (53%) or the mandible (47%). 
Most lesions were in the anterior regions of the jaws (59%). The most common location was in the 
anterior maxilla (41.2%) followed by the posterior mandible (35.3%), anterior mandible (17.6%), and 
posterior maxilla (5.9%).
AOT showed an equal distribution of the tumors between maxilla (50%) and mandible (50%). 
Most lesions were in the anterior regions of the jaws (89%). The most common location was in the 
anterior  maxilla  (50%) followed  by anterior  mandible  (39%),  and  then  posterior  mandible  (11%). 
Ameloblastic fibroma showed a significant predilection for mandible (73%) in comparison to only 27% 
in the maxilla. For Odontogenic myxoma there was a significant predilection for the location of the 
lesion in the mandible. 
Jing et al in 200619 did a study titled “Odontogenic Tumors: a retrospective study of 1642 cases 
in a Chinese population”. 75.5% of the lesions were located in the mandible, especially in the molar 
(23.6%) and angle (23.5%) regions, with an overall maxilla: mandible ratio of 1:4.0. The most frequent 
tumor seen in the maxilla and the ramus of the mandible was keratocystic odontogenic tumor, and 
ameloblastoma was the most common tumor in the anterior, premolar, molar and angle regions of the 
mandible. Calcifying cystic Odontogenic Tumor (CCOT) showed a predilection for maxilla (63.9%), 
whereas  most  of  the  other  odontogenic  tumors  were  more  common  in  the  mandible.  AOT  and 
ameloblastic  fibroodontoma  occurred  with  an  equal  frequency  (1:1  ratio)  in  the  maxilla  and  the 
mandible. 
Olgac et al  in 200620 studied 527 cases of Odontogenic Tumors  in Istanbul.  The posterior 
mandible was the commonest site (n=184, 35%), followed by the premolar area of the mandible (n=98, 
19%), and anterior maxilla (n=84, 16%). The mandible was more commonly involved by all tumors, as 
there  were  351  cases  in  mandible  and  176  cases  in  maxilla,  the  ratio  being  1.9:1,  and  this  was 
particularly prominent for ameloblastomas (mandible: maxilla ratio 7.8:1) and complex odontomas. 
Most of the cases of compound odontomas were found in  the maxilla,  particularly in  the anterior 
region. Odontogenic myxomas occurred equally in both jaws. 
Okada et al in 200721 conducted a study titled “Odontogenic Tumors in Sri Lanka: Analysis of 
226 Cases”. The mandible (180 cases; 79.6%) was 3.9 times more frequently affected than the maxilla 
(46 cases; 20.4%). In the mandible, the most frequently affected region appeared to be the posterior 
part (109 cases; 60.6%) whereas, in the maxilla, it was the anterior part (22 cases; 47.8%). Most of the 
ameloblastomas (148 cases;  94.3%) occurred in  the mandible  (maxilla:  mandible  ratio,  1:16.4).  In 
contrast, calcifying odontogenic cyst (2.3:1) and adenomatoid odontogenic tumor (1.3: 1) were more 
common in the maxilla. Furthermore, ameloblastoma showed a marked predilection for the posterior 
part of the mandible (100 cases, 63.7%), but adenomatoid odontogenic tumor was more common in the 
anterior part of both the maxilla and the mandible (a total of 15 cases, 9 in the maxilla and 6 in the 
mandible).
Sriram et al in 200822 retrospectively analyzed 250 cases of odontogenic tumors registered 
over a period of 36 years in an Indian teaching hospital in Mumbai, India. Mandible was clearly the 
most  preferred  site  for  occurrence  of  most  of  the  odontogenic  tumors,  with  a  ratio  of  3.8:1. 
Ameloblastoma showed a very high predilection for the mandible with 94.7% of the cases occurring in 
the  mandible  with  a  ratio  of  18.1:1.  In  general,  the  odontogenic  tumors  were  most  commonly 
encountered in the posterior zones of the jaws, but AOT defied this general finding and preferably 
affected maxilla with a maxilla: mandible ratio of 2:1. Cases of odontogenic tumors that involved more 
than  2  areas  of  the  jaws  were  AOT  and  ameloblastoma.  A  total  of  22.8%  of  the  mandibular 
ameloblastomas involved the full length of one-half of the mandible, and some extended to opposite 
side. 
 MATERIAL AND METHODS
This  retrospective study is  based on the data of all  Odontogenic Tumors managed in Tamil  Nadu 
Government Dental  College and Hospital  from February 1970 to March 2008. The histopathology 
record files from the Department of Oral and Maxillofacial Pathology  were retrieved and reviewed 
retrospectively for all the cases diagnosed as odontogenic tumors during a period of 38 years (1970- 
2008). Out of the total 11,843 oral biopsies registered during this period, 498 cases were reported under 
odontogenic  tumors.  The  clinical  information  with  respect  to  patient’s  age,  gender  and  anatomic 
location of the tumor was obtained from the biopsy records. The information regarding the extent of the 
lesion,  radiographic  interpretation  and macroscopic details  of  the  post  surgical  specimen were  not 
available for most of the lesions, so these parameters were not included in our study. In the present 
study  the  odontogenic  tumors  were  reviewed  according  to  the  1992  WHO  classification  for 
odontogenic tumors (Annexure II).28  
The hematoxylin and eosin stained slides of the respective cases were reviewed, and where necessary 
additional  H&E sections  were  made  by  retrieving  the  available  wax  blocks  from  the  department 
archives. 
Using  the  Leica  microtome,  4  micron  meter  thick  sections  were  cut  from the  blocks  for  Ehrlich 
Hematoxylin and Eosin staining. 
Procedure for Hematoxylin and Eosin staining27
• Sections are deparaffinised with xylene.
• Hydration with descending grades of alcohol.
• The sections are drained and transferred to hematoxylin, where they are left for 10 minutes.
• The slides are then drained and washed in running water until the sections are blue.
• The sections are dipped in acid alcohol where they are agitated for a few seconds and again 
washed in running water until blue again.
• The sections are counterstained with eosin for 30 seconds.
• The sections are washed in running water for 3-4 minutes, to differentiate the eosin. 
• After draining, the sections are dehydrated in ascending grades of alcohol.
• The sections are cleared with xylol, where they are given two changes for 30 seconds each.
• The sections being clear, the slides are dried and mounted with Distrene 80 Dibutyl phthalate 
Xylol (DPX) under a coverslip.
The stained and mounted slides for all cases were examined under the light microscope to confirm 
the previous histopathologic diagnosis. 
Results:
1. Nuclei:          Blue
2. Cytoplasm:    Varying shades of pink
The previously rendered diagnosis were re-evaluated and confirmed or modified. Based on this review, 
9 cases did not qualify for the diagnosis of odontogenic tumors as they were considered to be other than 
odontogenic in origin and thus excluded from our study. In the case of recurrent tumors, the histology 
of the primary and the recurrent tumor were compared and they were considered as one case.
Attempts were made to identify the incidence of these lesions in similar teaching institutes in other 
parts of India in order to study the overall prevalence. In this context, a questionnaire regarding the 
prevalence  study being  conducted  was  sent  through  various  sources  of  communication  to  various 
teaching  hospitals  including  government  and  non-  government  institutions,  across  the  country 
(annexure I). There are around 104 colleges in India offering MDS courses; of these, only 53 colleges 
conduct post graduation study in Oral Pathology29. From this, 25 colleges were short-listed on the basis 
that the oral pathology department in these colleges would be at least 10-20 years old to have sufficient 
number of cases to be able to conduct a prevalence study.   But the information provided was not 
sufficient enough for any meaningful contribution.
For the present study, distribution according to age, gender, and the prevalent location of each tumor, 
was determined.  With regard to the site of occurrence, both maxilla and mandible were divided into 2 
anatomic regions: anterior and posterior segments. In order to establish the changing pattern of tumor 
distribution in different age groups, the cases were categorized into decades.  All the information and 
data  were  compiled  and  statistically  analyzed  using  the  SPSS  for  Windows  statistical  software. 
Statistical analysis of the relation between different variables was performed using the chi-square test 
and ANOVA followed by Student-Newman-Keuls test.  The critical level of significance was set at P< 
0.05.
The P value between 0 to 0.01= the observation/result is significant at 1% level.
 The P value between 0.011 to 0.05= the observation/result is significant at 5% level.
The P value >0.05= the observation/result is not significant at 5% level.
               OBSERVATIONS & RESULTS
This retrospective study was conducted to review the 498 cases diagnosed as odontogenic tumors out 
of  11,843  oral  biopsies  registered  in  the  records  of  Oral  Pathology  Department  of  Tamil  Nadu 
Government Dental College, Chennai. After reviewing the H & E stained slides, 9 cases were excluded 
from  our  study  population  as  they  were  found  to  be  non-odontogenic  in  origin.  The  489  cases 




 The odontogenic tumors in this study population affected the patients over a wide age range of 5 - 75 
years with a mean age of 32.64 years. Age distribution of all 489 cases showed a peak occurrence in 2nd 
and 3rd decade of life with 53.17% of the cases in these decades. 
Table 1:  Distribution of patients by age group (in decades)


























Gender analysis of the patient population showed a slight male predilection. Among the 489 cases, 254 
were male (51.94%) and 235 (48.06%) were female patients, with an overall M: F ratio of 1.08:1. 







 The mandible was clearly the most commonly affected site for most of the odontogenic tumors with 
362 cases (74.02%) occurring in the mandible.  Mandible was 4 times more frequently affected than the 
maxilla  (90 cases;  18.4%).  In the mandible,  the predominantly affected region appeared to  be the 
posterior part (259 cases; 71.54%). In the maxilla, it was the anterior part (57 cases; 63.33%) that was 
prominently involved. The site of involvement of lesions was not specified in 28 cases. 
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VARIABLES RELATED TO INDIVIDUAL ODONTOGENIC TUMORS 
Incidence of odontogenic tumors over decades (1970-2008):
The incidence of odontogenic tumors was assessed in four decades from 1970-2008. Our study shows a 
sudden increase in the number of cases from 1970-1980 to 1981-1990 correlating with the increase in 
number of total received biopsies. In the following decade there is an increase in the number of the 
odontogenic tumors even though the total number of received biopsies is relatively lesser. Our study 
also reveals a trend towards increase in both the number of total cases and odontogenic tumors in the 
recent years. 
Fig.4    






Frequency of odontogenic tumors over 4 decades (1970-2008):
Year in decades Odontogenic
Tumors  per 
decade 
Total  No.  of 




1970 – 1980    Benign
                       Malignant





1981 – 1990     Benign
                         Malignant





1991 – 2000      Benign
                          Malignant





2001 – 2008      Benign
                          Malignant





Total 489 11843 4.13%
Of these 489 cases, 474 cases (96.93%) were benign tumors and 15 cases (3.07%) were malignant. 
Table 5:
General frequency of odontogenic tumors:





              





Of the benign tumors, ameloblastoma was the most frequently observed lesion accounting for 67.68% 
(n=331),  followed  by  AOT  (n=44,  9%),  odontomas  (n=38,  7.77%),  COC  (27cases,  5.52%),  and 
odontogenic myxoma (n=13, 2.65%). Of the 38 odontomas, 27 were complex and 11 were compound 
odontomas in  nature.  All  the malignant tumors were found to be primary intraosseous carcinomas 
(n=15, 3.06%). 
Table 6: The distribution of histological types of odontogenic tumors:-  
Of the benign tumors, ameloblastoma was the most frequently observed lesion accounting for 67.68% 
(n=331),  followed  by  AOT  (n=44,  9%),  odontomas  (n=38,  7.77%),  COC  (27cases,  5.52%),  and 
odontogenic myxoma (n=13, 2.65%). Of the 38 odontomas, 27 were complex and 11 were compound 
odontomas in  nature.  All  the malignant tumors were found to be primary intraosseous carcinomas 
(n=15, 3.06%). 
Fig. 6






























Gender distribution of individual odontogenic tumor: 
 Of the 474 cases of benign tumors, 249 (52.53%) were diagnosed in male patients and 225 cases 
(47.46%) were in female patients (the M: F ratio being 1.1:1). Ameloblastomas, odontomas and CEOT 
affected male patients more than female patients, whereas AOT, squamous odontogenic tumor, benign 
cementoblastoma and ameloblastic fibroma were seen more in female patients. Further observation 
showed that malignant odontogenic tumors were 2 times more common in females than male patients, 
as of the 15 cases, 10 were female patients and 5 were male patients (the M: F ratio being 1:2). 


































AOT-44 21 47.72 23 52.27 1:1.09
SOT-3 1 33.33 2 66.66 1:2
CEOT-4 3 75 1 25 3:1
AF-6 1 16.66 5 83.33 1:5
AOF-1 1 100 0 _ 1











MYX-13 6 46.15 7 53.84 1:1.16
OF-2 2 100 0 _ 2
BC-4 1 25 3 75 1:3
CCOT-1 0 _ 1 100 1
PIOC-15 5 33.33 10 66.66 1:2
Fig.7
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Ameloblastoma, the most common tumor in this study showed a peak occurrence with 100 out of 331 
cases (30.21%) in  3rd decade and almost  equal  number of cases in  2nd,  4th and 5th decades.  It  was 
observed that in younger age group (2nd decade), relatively more number of patients were affected by 
unicystic  ameloblastoma than  solid  ameloblastoma.  AOT,  the  second most  common tumor  in  this 
series, showed a peak incidence in 2nd decade, with 33 out of 44 cases (75%) occurring in 2nd decade. 
AOT affected  patients  between  the  age  range  of  9  to  30  years  with  a  mean  age  of  16.84  years. 
Odontomas also predominantly occurred in 2nd decade with 24 of 38 cases (65.78%) in this age group. 
Ameloblastic fibroma mainly affected younger patients as 4 out of 6 cases were seen in 1st and 2nd 
decade. Primary intraosseous carcinoma occurred more in older patients (6th decade). 
Table 8:  The age distribution of individual odontogenic tumors according to decades:  
 
Site distribution of individual odontogenic tumors: 
 
Four hundred and eighty cases (98.15%) of all odontogenic tumors were intraosseous whereas only 9 
lesions (1.85%) were extraosseous or peripherally located. The peripheral lesions included 1 case of 
AOT, 1 of odontogenic fibroma and 7 cases of ameloblastoma. 
Table 9: 












 Ameloblastoma showed a very high predilection for the mandible with 90.33% of the cases occurring 
in the mandible (mainly posterior region). The mandible: maxilla ratio being 12:1 for ameloblastoma. 
Odontogenic myxoma (46.15%), ameloblastic fibroma (83.33%) and PIOC (93.33%) also occurred 
more in  posterior  mandible.  In  contrast  to  the general  mandible  predominance shown by all  other 
tumors, maxilla was predominantly affected by AOT with 29 out of 44 cases occurring in the maxilla 
(mainly  anterior  region).   44.73% of  odontoma  cases  occurred  in  anterior  maxilla  and34.21% in 
posterior mandible.
Table 10:   The distribution of individual odontogenic tumors according to anatomic location:  
Individual tumors:
Three hundred and thirty one cases were diagnosed as ameloblastoma, which corresponded to the most 
frequent  odontogenic tumor,  accounting for  67.7% of  all  cases.  The lesion predominantly affected 
males (178 cases) with an M: F ratio of 1.16:1. The majority of the lesions occurred in mandible (299 
cases) and only 25 cases were seen in maxilla, with a mandible: maxilla ratio being 12:1. In both the 
maxilla and the mandible, posterior region was mainly affected. The highest incidence was observed in 
3rd decade of age with 30% cases, whereas 2nd, 4th, 5th and 6th decades were involved with almost an 
equal frequency of 16% cases in each decade. Ameloblastoma affected patients over a wide age range 
of 5-75 years with the mean age of 35.69 years.  There were 207 cases of solid type, 117 of unicystic 
type and 7 were peripheral ameloblastomas. The peripheral ameloblastoma constituted 2.11% of all 
ameloblastomas, Of the 7 peripheral cases, 5 occurred in anterior regions (3 in anterior mandible and 2 
in anterior maxilla) and only 2 in posterior regions (one each in maxilla and mandible). 
AOT was the second most common lesion in this series, as 44 cases (9%) of AOT were identified in 
this study. The lesion occurred in 21 males and 23 females. The patients were affected the most in their 
2nd decade of life with a mean age of 16.84 years. The most commonly affected site was anterior 
maxilla with 27 out of the 44 cases in this region. Fourteen cases were found in the mandible, and of 
the 14 cases, 10 cases were present in anterior mandible and 4 cases in posterior mandible. Majority of 
the cases (n=31, 70.45%) were follicular variants of AOT, associated with an impacted tooth (mostly 
maxillary canine), whereas only 12 cases (27.27%) were the extrafollicular type. The rare peripheral 
type (2.27%) occurred in anterior maxilla. 
Thirty eight cases of odontomas were identified, constituting 7.77% of the study population. There 
were 27 (71.05%) complex and 11 (28.95%) compound type odontomas. The highest incidence was 
observed in 2nd decade of life with 24 (65.78%) out of 38 cases in this group and mean age of 17.81 
years for compound and 24.46 years for complex odontoma. The youngest patient to present with the 
lesion was 7 year old with compound odontoma and the oldest  was 67 years old with a complex 
odontoma. The lesion affected 20 male and 18 female patients. The predominantly involved segment 
was anterior maxilla with 17 cases in this region, followed by 13 cases in the posterior mandible. 
Thirteen cases of odontogenic myxoma were found, corresponding to 2.65% of all the odontogenic 
tumors. This lesion affected both sexes almost equally (6M: 7F) with no gender predilection. Mandible 
was predominantly involved with 10 cases in mandible, mainly the posterior region  and only 3 cases in 
maxilla. 69% of the cases were seen in 2nd and 3rd decade with a mean age of 24 years. 
Ameloblastic fibroma, representing 1.22% of all odontogenic tumors in our study was an uncommon 
tumor  type,  affecting  6 patients  over an age range of  6-40 years with a mean age of 19.83 years. 
Females were predominantly affected,  and  M: F  ratio  being 1:5. Of the 6 cases, 5  (83.33%)  were 
present in posterior mandible and only one case in anterior maxilla.
Fifteen cases (3.06%) were diagnosed as primary intraosseous carcinomas, the only type of malignant 
tumor seen in  this  series.  This malignancy affected females  (10 cases)  two times more than male 
patients (5 cases).  The patients ranged in age from 21 to 75 years with a mean age of 57.93 years. 
Majority of cases occurred in 6th decade of lifelife. The neoplasm was seen exclusively in the posterior 
segments of both the jaws., and theThe posterior mandible was clearly the most frequently affected site 
with 14 out of 15 cases in this region, . and only one cases in posterior maxilla.  
Other odontogenic tumors included three squamous odontogenic tumors (0.6%), four cases each (0.8%) 
of  benign  cementoblastoma  and  calcifying  epithelial  odontogenic  tumor,  two  cases (0.4%) of 
odontogenic fibroma, and one each (0.2%) of ameloblastic fibro-odontoma and clear cell odontogenic 
tumor. 
RELATION  BETWEEN  DIFFERENT  VARIABLES  RELATED  TO  ODONTOGENIC 
TUMORS
Age –Sex Correlations:- 
Further observations revealed that in 2nd, 4th, and 6th decades there were more female patients than 
male patients, whereas in 1st, 3rd, 5th, 7th, and 8th decades male patients predominated. 
Table 11.   
Age  in 
decades
No.  of  cases 
per decade
No.  of  male 
patients
No.  of  female 
patients
M:F Ratio
0-10 14 9 5 1.8:1
11-20 131 59 72 1:1.2
21-30 129 70 59 1.18:1
31-40 66 29 37 1:1.27
41-50 61 39 22 1.77:1
51-60 63 28 35 1:1.25
61-70 22 18 4 4.5:1
71-80 3 2 1 2:1
The χ2= 18.14525, P=.00588 i.e.> 0.005**denotes the significance at 5% level. 
The table 12 shows the difference in the mean ages of occurrence of individual lesions in male and 
female patients, which was not found to be statistically significant except for compound odontomas. 
  
  Table 12. 
    
     Odontogenic tumors
              Mean age (in years)









Ameloblastic Fibroma 22 19.4
Odontogenic myxoma 20.83 27.14
Compound Odontoma 12.83 23.8
Complex Odontoma 25.5 21.46
PIOC 57.6 58.1
Age-Site Correlations:-
  Table 13.  
Age  in 
decades
Total  no. 
of cases
Mandible Maxilla Peripheral NS
0-10 14 4 7 3 0
10-20 131 86 39 1 5
20-30 129 93 21 1 14
30-40 66 58 3 1 4
40-50 61 47 9 2 3
50-60 63 53 8 0 2
60-70 22 19 3 0 0
70-80 3 2 0 1 0
Table 13 depicts the correlation between the various anatomical sites affected in different age groups. 
The statistical analysis revealed a significant difference as mandible was the mostly affected site in all 
other decades (P<0.001**) except in first decade when more lesions were seen in the maxilla than in 
the mandible. 
Table 14. 








Table 14 shows that as the age increases, the site of involvement changes and in older patients lesions 
occur more in posterior than anterior regions. This observation was statistically significant, P<0.001**.
Table 15.




The mean age of the patients affected by benign odontogenic lesions was significantly lower than the 
mean age of patients with malignant odontogenic tumors (P< 0.001**). 
Table 16.









The difference in the mean age of the above stated lesions was found to be statistically significant 
(P<0.001**) as the mean age of patients with AOT was significantly lower than the mean age for other 
lesions.
Sex- site correlation:-   
Table 17.   
Gender Mandible Maxilla Peripheral  N/S
Male 186 47 6 15
Female 176 43 3 13
χ2= .85993, P=.83508 means P>0.05 so  statistically not  significant, means that the difference in the 
relative number of sites involved in male and female patients was not statistically significant.
Table 18.  
                     
The above two tables depict the correlation between the affected sites among males and females. The 
statistical  analysis  revealed no significant  difference between site of involvement among male and 
female patients [P=0.835,(, (P>0.05)].
DISCUSSION
The results of the present study showed that odontogenic tumors occur at a frequency of 4.13% 
of the total biopsied specimens registered in the department. It also revealed a gradual increase in the 
number of cases recorded (62/2029 cases) in the first decade with a percentage of 3.05% compared to a 
higher number of cases (161/3625 cases) during the current decade with 4.44%. 
 The great bulk of the odontogenic tumors were ameloblastomas, which comprised a total of 331 
cases  (67.68%) out  of  a total  of  489 odontogenic tumors.  The ameloblastomas were grouped into 
central (97.88%) and peripheral lesions (2.11%). Within the central lesions they were sub classified 
into solid (63.88%) and unicystic (36.11%). Solid ameloblastoma formed a total of 207 cases with an 
overwhelmingly higher proportion of the cases found in the mandible (90.33%) than the maxilla. The 
second most  prevalent  tumor was the  AOT with  44 cases  (43 intraosseous  and 1 peripheral,  9%) 
followed by odontomas (38 cases, 7.7%), COC (27 cases, 5.5%), PIOC (cases 15, 3%) and odontogenic 
myxoma (13 cases, 2.6%). The rest included clear cell odontogenic tumor, ameloblastic fibroodontoma, 
odontogenic fibroma, SOT, benign cementoblastoma, CEOT and AF between 1-6 cases. Over 50% 
odontogenic tumors were found in the second and third decades of life. 
The single most frequent site of involvement for odontogenic tumors was the mandible (362 
cases,  74.03%).  The  overall  gender  distribution  of  odontogenic  tumors  showed  a  slight  male 
predilection with 51.94% (254/489 cases) in males and 48.06% (235/489 cases) in females.
Information derived from the literature indicates that  large published series on odontogenic 
tumors from Indian population is limited to a single publication.22 Literature search also revealed no 
other  published  series  on  odontogenic  tumors  in  the  adjoining  countries  like  Bangladesh,  Bhutan, 
Myanmar,  Nepal,  and Pakistan except a single report  from Sri  Lanka.21 The present study,  on the 
descendants of the Dravidian race concentrated at the tip of India, Chennai, Tamil Nadu, is based on a 
larger sample (489 cases) of odontogenic tumors among the population registered in the Department of 
Oral & Maxillofacial Pathology of the Tamil Nadu Government Dental College & Hospital, Chennai, 
Southern India. This study on a sample size of 489 cases spread over a period of 38 years (1970-2008) 
represents the single largest series from this part of the world. 
The epidemiological data regarding the overall global prevalence of odontogenic tumors vary 
among different  geographical  locations  and populations  from as  low as  0.74% to  as  high  as  32% 
(annexure III & IV).  This wide variation may be partly attributed to the variation in the parameters 
employed by researchers around the world. This is evident from the fact that some researchers have 
included only central  lesions  in  their  analysis,  while  others  have  included  peripheral  lesions3,11 or 
disregarded odontomas.42 Still others have addressed either only benign odontogenic tumors46 or tumors 
of  ectodermal  origin,14 and  on occasion,  only peripheral  odontogenic lesions.30,49  Further  more,  the 
variations may be related to the differences in arriving at the overall percentage of prevalence, where 
some studies  have considered prevalence of  odontogenic tumors  as  a percentage of  all  tumor and 
tumor-like lesions of the oral and peri-oral regions. 2,4,8,13,16,20  In the present study, like many other 
studies, 3,9-12,15,17,18  odontogenic tumors were considered as a percentage of the total biopsied samples.
The incidence of 4.13% of odontogenic tumors  found in  the present  study although higher 
compared  to  studies  from  American  population, 9,12,18  is  substantially  lower  compared  to  reports 
(8.6-32%)  from the  studies  on  African  population. 2,3,4,7,8,24,25,26 Odontogenic  tumors  were  found  in 
patients over a wide age range of 5-75 years with a mean age of 32.64 years. They were found to be 
most frequent in the second through sixth decades with peaks in the second and third decades of life. 
The high number of ameloblastomas found in this study, like the observation made by Ladeinde et al, 3 
Fernandes et al  17  and Okada et al, 21 might have invariably contributed to the higher prevalence of 
odontogenic tumors in the second and third decades of life. Similar observation of high prevalence of 
odontogenic tumors in the second decade were also observed by Santos et al 11and Tamme et al, 15 but 
this was perhaps more due to the number of odontomas in their study. Other studies 4, 8, 10, 14,16,19,22 have 
reported prevalence in the third decade of life; again, the ameloblatomas formed the bulk of the cases in 
that  age group.  Still  others  have assessed the prevalence of  odontogenic tumors  in  childhood and 
adolescence, restricting the scope for any meaningful comparison. 24,25,42,47
The sex predilection for odontogenic tumors is equivocal in the literature. The present study 
revealed a slight male predominance (Male: Female=1.08:1).  This figure is  comparable with many 
series, 2,3,4,6,8,10,14,19,22 though others have found a female predominance. 9, 11, 12, 15, 17, 20, 21
There is  still  a lack of agreement  on the most  frequently encountered type of  odontogenic 
tumors. The most prevalent tumor in the present study was ameloblastomas similar to the previously 
reported  series  from  African  and  other  Asian  populations.  2,3,8,10,14,16,17,19-24 Even  in  the  American 
population,  9,12,15,18,25 ameloblastoma were still the most frequent odontogenic tumor, especially when 
odontomas were disregarded. Our study identified AOT to be the second most frequent odontogenic 
tumor with 44 cases (9%) followed by a marginally less number of 38 cases (7.7%)  of odontomas and 
COC (27 cases, 5.5%).
There  is  general  consensus  among  researchers  with  regard  to  the  most  afflicted  site  of 
odontogenic tumors. In the present study, mandible was the predominantly affected site with 362 cases 
as opposed to 90 cases in the maxilla with the maximum number of cases concentrated in the posterior 
region (259 cases). This observation is shared by many previous studies. 2-4, 6-25 The anterior segment of 
the maxilla (57 cases) was affected more often compared to the anterior segment of the mandible (51 
cases). The lesions that were found to occur more in the anterior maxilla were AOTs (26 cases) and 
odontomas  (17  cases).  On the  other  hand,  ameloblastomas  were  identified  more  frequently  in  the 
anterior  mandible  (30  cases).  The  predominance  of  AOT in  the  anterior  maxilla,  observed in  the 
present study, is similar to the observation noted on African and other Asian populations. 4,8,10,21,22,24 The 
higher  prevalence  of  ameloblastomas  in  the  anterior  mandible  observed  in  the  present  series  is 
comparable to the reports from studies on Brazilian, African and Asian populations, 4,8,10,17,19,21,22,24 while 
results of the European and American studies 9,11,12,15,20 have shown odontomas to be the most prevalent 
odontogenic lesion in the anterior segment of both the maxilla and mandible.
The interpretations of the above observations indicate that ameloblastoma is the most frequent 
odontogenic tumor, when odontomas are excluded, irrespective of ethnic or geographic populations. 
In the context of Indian population only one published report involving a considerably large 
series spanning over decades is available for comparison to elicit subtle differences. The report by 
Sriram  &  Shetty,  22  involving  largely  Maharastrian  population  in  one  of  the  most  populated 
metropolitan cities in India, revealed that ameloblastoma is the most frequent odontogenic tumor akin 
to  our  observation  and  others.  Their  study also  found  ameloblastoma to  be  more  frequent  in  the 
mandible than the maxilla with a ratio of 18.1:1. The ratio for mandible to maxilla found in our study 
was 12:1. When all ameloblastomas were considered the mandible was affected in 90.33% of cases in 
our series. But when the percentage of ameloblastoma was arrived for intraosseous lesions the result 
was 92.28% as opposed to a marginally higher value of 94.7% observed by Sriram & Shetty.22 The 
incidence of central ameloblastoma with 66.25%, observed in the present study, is more than the 61.6% 
observed in their  study,  and the total  number (331) of ameloblastoma represents the largest  single 
institutional study in Tamil linguistic people of Dravidian origin in India. Moreover, our study revealed 
63.88%  (207  cases)  to  be  of  solid  ameloblastoma  while  36.11%  (117  cases)  were  of  unicystic 
ameloblastoma,  when  intraosseous  ameloblastoma  were  exclusively  taken  into  consideration.  The 
global frequency of unicystic ameloblasoma was in the range of 6% - 32%. Our figure of 36.11%, 
although high, is close to that reported by Okada et al 21 (31.41%) for the Sri Lankan population. There 
was more number of solid ameloblastomas in the mandible with 62.54% as opposed to 37.45% for 
unicystic ameloblastoma. When the anterior region of the jaws was considered for both variants of 
central ameloblastoma, the incidence of 11.72 % was significantly more than the 7.2% observed by 
Sriram & Shetty.22   The value obtained for Dravidian population in the present study is in agreement 
with the observation made by Riechart et al.50 
Our  study  also  noted  differences  between  gender  groups  with  regard  to  ameloblastoma 
subtypes; solid ameloblastoma occurred more frequently in males, whereas unicystic ameloblastoma 
showed  predilection  for  females.  Although  our  observation  of  a  female  predominance  for  cystic 
ameloblastoma  is  consistent  with  Buchner  et  al18 &  Okada  et  al, 21 others  have  observed  a  male 
predilection.34,35,36
In the present study more cases of unicystic ameloblastomas were seen in the second decade 
than solid ameloblastomas. The mean age of occurrence of ameloblastomas was 37.4 years for solid 
ameloblastomas and 32.7 years for unicystic ameloblastomas (117/324 cases) but was only 23.11 years 
for unicystic ameloblastoma that were associated with an unerupted tooth (17/117 cases). The second 
and third decade involvement by unicystic ameloblastoma has also been reported in the literature.34,35 
Peripheral  ameloblastoma  constituted  2.11%  of  all  ameloblastomas  similar  to  the  data  found  by 
Reichart  et  al.50 They occurred more in the incisor molar-premolar region than in the molar-ramus 
region. In general, posterior region of the mandible was the preferred site for both unicystic and solid 
ameloblastomas but peripheral ameloblastoma tend to occur more anteriorly.
The AOT was the second most common odontogenic tumor (44/489 cases) encountered in our 
study. It was termed as AOT by Philipsen & Birn.39 AOT can exist in 3 clinico-topographic variants 
namely, follicular, extrafollicular and peripheral. The relative incidence of this entity ranges from 0.6% 
to 38.5% and is more prevalent in the African population than elsewhere.41 In the present analysis, 
although 1/3 (14/44 cases) of AOT occurred in the mandible, it was the most common tumor in the 
maxilla with an incidence of 6%, and an overall prevalence of 9% in both jaws. The other reports from 
India  and  the  neighboring  Sri  Lanka,21,22   like  our  observation  in  the  Tamil  linguistic  people  of 
Dravidian origin, indicated that AOT has more probability of occurrence in the maxilla than any of the 
odontogenic tumors, especially in younger individuals. It also revealed that AOT is the second most 
frequently encountered odontogenic tumor in India  and Sri  Lanka.21,22  In our study AOT affected 
patients in the age range of 9 to 30 years with a mean age of 16.84 years. The mean age found in the 
Dravidian  population  was  comparatively  lower  than  the  mean  age  of  18.2  years  and  19.4  years, 
reported by the Sri Lanka21 and the Maharastrian population in India, 22 respectively. 
Though the literature41 showed AOT to be most frequent in females, gender involvement was 
almost equal with regard to the occurrence of follicular variants of AOT (15 females, 16 males) but 
slightly more extra follicular variants were found in females (7/43 cases) than in males (5/43 cases) in 
our analysis.  In the present study,  75% of AOT occurred in younger patients (2nd decade) similar to 
other series.3,4,8,10,11,17,19,21,22,39  However, when compared to ameloblastomas (mean age, 35.69 years), the 
mean age for AOT was found to be quite low, i.e., 16.84 years. The difference is statistically significant 
(Table 12).
Assessment of the exact frequency of odontomas is complicated by the fact that it is omitted in 
some  analysis.  Yet  the  literature  shows  a  significant  difference  as  to  the  relative  frequency  of 
odontomas  that  varied  between  Nigerian3 and  North  California18 populations  with  2.5%  to  76%, 
respectively. The extreme variations in the frequency of odontomas could possibly suggest a racial 
affect, in that its prevalence was low in the African and other Asian populations2-4,8,10,16,21-24 compared to 
others.9,11,12,15,17,18,20,25  In the present study the frequency of odontomas was 7.8%  which is comparably 
higher than China (6.7%), 10 other Indian study (6%), 22 and Sri Lanka (4.4%).21
Odontomas in the present study showed a slight male predominance, similar to the observation 
by Fernandes et al,17 Buchner et al,18 & Olgac et al.20 It occurred mostly in younger individuals with a 
mean age of 21.89 years. Over 65.8% were found in individuals less than 20 years of age but patients 
afflicted with compound odontomas (mean age, 17.81 years) were considerably younger than those 
with complex odontomas (mean age, 24.46 years). These observations are consistent with the reports 
from elsewhere.10,12,15,17,19,21 Complex odontomas tend to occur more frequently than the compound type, 
an observation in agreement with most others. 10,12,15,17,19,20 The reverse trend was noted in one single 
study.21 The tendency to  occur  in  the anterior  region  (57.9%) was more  than  the  posterior  region 
(42.1%) of both the jaws. Similarly, the anterior maxilla was the preferred site followed by posterior 
mandible and posterior maxilla. Unlike the Sri Lankan study, 21 where more compound odontomas were 
found in the anterior mandible, compound odontomas in the present series tends to occur more often in 
the  anterior  maxilla,  while  complex  odontomas  were  found  in  the  posterior  mandible.  These 
observations are shared by some but not others.9,10,11,12,17,19,20,22 The study on the Maharastrian population 
in  India22 which  although  did  not  specify  the  type,  have  found  more  odontomas  in  the  posterior 
mandible.
COC represents 5.52% with 27 cases. The male to female ratio was found to be 1.07:1 with 
51.85% in males and 48.14% in females. The mandible was the most frequently involved site in over 
74% of cases. When the ratio of ameloblastoma to COC was assessed, the ratio of 12:1 was found to be 
lower  compared  to  the  observation  by  Sriram  and  Shetty22 (22:1).  When  only  the  unicystic 
ameloblastomas were compared, the difference narrowed to a ratio of 4.3:1, similar to the Sri Lankan 
Study.21 in the present study the mean age (32.59 years) and peak incidence for COC was similar to that 
found for unicystic ameloblastomas, while COC tend to occur more frequently in males. The mean age 
and male predilection observed in the present study was at variance with the observation made by 
Sriram and Shetty22 but concurs with the Sri Lankan study.21 
Odontogenic myxoma was first described by Thoma and Goldman in 1947. It is unique to the 
jaws  and  has  predilection  for  the  posterior  region,  and  occurs  at  a  relatively  younger  age  group 
compared to ameloblastoma. There have been only few published series involving a significantly large 
number  of  patients.  The  frequency  of  2.65%  odontogenic  myxoma  in  the  present  analysis  was 
comparable with others. However, no significant gender distribution was noted in the present series. 
The  mean  age  of  24.23  years  for  odontogenic  myxoma  was  significantly  lower  than  that  for 
ameloblastoma (35.7 years) in the present series, and was in agreement with Sriram and Shetty.22 The 
frequency of this tumor in the mandible than in the maxilla (3.33:1) was comparable to most other 
reports but was at variance with Sriram and Shetty (1:1). This indicated that maxillary odontogenic 
myxomas were uncommon in the population groups studied by us.
Ameloblastic fibroma and ameloblastic fibro-odontoma comprised a total of 7 cases with six of 
the former and a single case of the latter, which together formed less than 1.5% of the sample. The low 
prevalence of these childhood odontogenic tumors in our sample correlated with Sriram and Shetty,22 as 
well as by others (annexure IV). An exceptionally high prevalence of 16 %, however, was found in an 
Estonian series.15 Both AF and AFO occurred mainly in the posterior region of the mandible with a 
single case of the former in the anterior maxilla. The predilection for posterior mandible was almost 
similar  in  both the Dravidian  population of  our  study and Maharastrian population  of  Sriram and 
Shetty.  In  the  neighboring Sri  Lanka where  a  substantial  Dravidian  population exists,  the  anterior 
maxilla was the most frequently involved site. While AF occurred in the age range of 6-40 years, the 
single case of AFO was found in a 5 year old boy. The mean average age of patients affected by AF 
was 19.83 years with a male: female ratio of 1:5.  The female predominance was in agreement with 
other reports.6,8,11,12,15,17,19,21,22  Contrary to our observation, Slootweg in an analysis of 55 cases, found a 
lower mean age of 14.6 years and a slight male distribution (52.7%). A higher mean age was observed 
by Sriram and Shetty (26.5 years) and in an Estonian series (39.2 years).15,22  The varied results need to 
be addressed by further investigation by others, especially in the Indian context.
The lesser number of other benign odontogenic tumors were negligible to draw any meaningful 
observation.  The  present  analysis  found  no  malignant  ameloblastoma  or  ameloblastic  carcinoma, 
especially in the setting of high frequency of ameloblastoma in our study. In fact three cases were 
coded as ameloblastic carcinoma but on review were found to be salivary gland adenocarcinomas. 
PIOC was the only malignant entity encountered in this analysis and represents 3.06% (15 cases) of 
odontogenic tumors. It was found to occur more in females and in the posterior mandible. 
.
SUMMARY 
The present study was designed to analyze the epidemiological information on odontogenic tumors of 
those patients who had undergone biopsy and whose data are registered in the Department of Oral 
Pathology & Microbiology, Tamil Nadu Government Dental College and Hospital,  Chennai, in the 
state  of  Tamil  Nadu,  India;  to  provide  the  data  in  the  context  of  patients  age,  sex,  site  and 
histopathological diagnosis for comparison with other studies and for future research purpose.  The 
retrospective study was conducted on a sample size of 489 cases diagnosed as odontogenic tumors out 
of the total 11,843 oral and maxillofacial biopsies registered in the Department of Oral Pathology over 
a  period  of  38  years  (February  1970  to  March  2008).  The  results  of  the  present  study  can  be 
summarized as below: 
The 489 cases constituted 4.13% of all the biopsy specimens registered over a period of 38 
years. Our study also revealed a gradual increase in the number of cases recorded (62 odontogenic 
tumors /2029 total cases) in the first decade (1970-1980) with a percentage of 3.05% compared to a 
higher number of cases (161/3625 cases) during the current decade (2001-2008) with 4.44%. 
The great bulk of the odontogenic tumors were ameloblastomas, which comprised a total of 331 
cases  (67.68%) out  of  a total  of  489 odontogenic tumors.  The ameloblastomas were grouped into 
central (97.88%) and peripheral lesions (2.11%). Within the central lesions they were sub classified 
into solid (63.88%) and unicystic (36.11%). Solid ameloblastoma formed a total of 207 cases with an 
overwhelmingly higher proportion of the cases found in the mandible (90.33%) than the maxilla. The 
second most  prevalent  tumor was the  AOT with  44 cases  (43 intraosseous  and 1 peripheral,  9%) 
followed by odontomas (38 cases, 7.7%), COC (27 cases, 5.5%), PIOC (cases 15, 3%) and odontogenic 
myxoma (13 cases, 2.6%). The rest included clear cell odontogenic tumor, ameloblastic fibroodontoma, 
odontogenic fibroma, SOT, benign cementoblastoma, CEOT and AF between 1-6 cases.
The odontogenic tumors in this study population affected the patients over a wide age range of 
5 - 75 years with a mean age of 32.64 years. Over 50% of odontogenic tumors were found in the 
second and third decades of life. 
The single most frequent site of involvement for odontogenic tumors was the mandible with 
362 cases (74.03%). In the maxilla, only 90 cases were identified that showed the anterior region to be 
most frequently involved in 63.33% (57 cases). 
The overall gender distribution of odontogenic tumors showed a slight male predilection with 
51.94% (254/489 cases) in males and 48.06% (235/489 cases) in females.
CONCLUSION: 
The present  series  on the Dravidian  population not  only reflect  differences  but  also shares 
similarities among the varied population samples assessed both within India and across the world. The 
incidence of 4.13% of odontogenic tumors, observed in this study, is the first report from this part of 
the world involving a largest series from the only Government institution under the Ministry of Health 
& Family Welfare, Government of Tamil Nadu, India. However, the prevalence of odontogenic tumors 
reported by this study should not be interpreted in the context of the whole population (predominantly 
Tamil linguistic people of Dravidian origin) as the hospital based study involves only those populations 
(Tamil  linguistic  people  of  Dravidian  origin)  that  had  attended  the  hospital  setting.  Further,  the 
population of any given groups do not remain static over the decades studied. 
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